Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC EHT 1610 | 1425945-60-3 | 98.9% | 383.40 | 100 MG
SDP

Catalog No. 5000344028
Encompass_Preferred

EHT 1610 is a potent inhibitor of DYRK family kinases, demonstrating strong activity against DYRK1A and DYRK1B. This compound exhibits antileukemia effects, modulates the cell cycle, and is capable of inducing apoptosis in various cell types. It is suitable for research applications exploring kinase inhibition and its cellular impacts.

  • Potent inhibitor of DYRK1A (IC50: 0.36 nM) and DYRK1B (IC50: 0.59 nM).
  • Exhibits antileukemia activity.
  • Regulates cell cycle progression.
  • Induces cell apoptosis.
  • Inhibits DYRK1A-mediated FOXO1 and STAT3 signaling.
  • Reduces leukemic burden in in-vivo models.

Catalog No. 50-003-44028 Supplier Medchemexpress LLC Supplier No. HY111380100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

EHT 1610 is a potent inhibitor of DYRK family kinases, demonstrating strong activity against DYRK1A and DYRK1B. This compound exhibits antileukemia effects, modulates the cell cycle, and is capable of inducing apoptosis in various cell types. It is suitable for research applications exploring kinase inhibition and its cellular impacts.

  • Potent inhibitor of DYRK1A (IC50: 0.36 nM) and DYRK1B (IC50: 0.59 nM).
  • Exhibits antileukemia activity.
  • Regulates cell cycle progression.
  • Induces cell apoptosis.
  • Inhibits DYRK1A-mediated FOXO1 and STAT3 signaling.
  • Reduces leukemic burden in in-vivo models.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.